CD5-Positive B cells in type 1 (insulin-dependent) diabetic children

R. Lorini, M. Massa, G. d'Annunzio, L. Cortona, F. De Benedetti, A. Martini, F. Severi

Research output: Contribution to journalArticle

Abstract

We have measured CD5+ B cell levels in the peripheral blood of 35 type 1 (insulin-dependent) diabetic children, aged 1.1-21.2 years (10.7 ± 4.6 years). Patients were divided into two groups according to disease duration (group I <6 months and group II > 1.5 years). Group I included 18 patients and group II 17 patients. Thirty-nine healthy subjects, comparable for age and sex, served as controls. CD5+ B cells were identified by double immunofluorescence staining with rhodamine-conjugated rabbit anti-human immunoglobulin and with a mouse anti-CD5 monoclonal antibody revealed by a fluorescein-conjugated goat anti-mouse immunoglobulin. We found that CD5+ B cell levels (expressed as percentages of peripheral blood B lymphocytes) were significantly higher in group I (median 24; range 4-48) than in controls (median 14; range 0-36, P <0.001) and in group II (median 4; range 0-20, P <0.001). A follow-up study of 12 group I patients showed a significant decline in CD5+ B cell levels. The data obtained in our diabetic patients suggest that CD5+ B cells are expanded in the early phase of type 1 diabetes mellitus and may play a role in the autoimmune process of the disease.

Original languageEnglish
Pages (from-to)17-22
Number of pages6
JournalDiabetes Research and Clinical Practice
Volume19
Issue number1
DOIs
Publication statusPublished - 1993

Fingerprint

B-Lymphocytes
Insulin
Immunoglobulins
Rhodamines
Fluorescein
Type 1 Diabetes Mellitus
Goats
Autoimmune Diseases
Fluorescent Antibody Technique
Healthy Volunteers
Monoclonal Antibodies
Staining and Labeling
Rabbits

Keywords

  • Antibodies
  • Autoimmunity
  • B-lymphocytes
  • CD5 B cells
  • Type 1 (insulin-dependent) diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

CD5-Positive B cells in type 1 (insulin-dependent) diabetic children. / Lorini, R.; Massa, M.; d'Annunzio, G.; Cortona, L.; De Benedetti, F.; Martini, A.; Severi, F.

In: Diabetes Research and Clinical Practice, Vol. 19, No. 1, 1993, p. 17-22.

Research output: Contribution to journalArticle

@article{dadce402e1b246d2abf5958bc8c5cd7b,
title = "CD5-Positive B cells in type 1 (insulin-dependent) diabetic children",
abstract = "We have measured CD5+ B cell levels in the peripheral blood of 35 type 1 (insulin-dependent) diabetic children, aged 1.1-21.2 years (10.7 ± 4.6 years). Patients were divided into two groups according to disease duration (group I <6 months and group II > 1.5 years). Group I included 18 patients and group II 17 patients. Thirty-nine healthy subjects, comparable for age and sex, served as controls. CD5+ B cells were identified by double immunofluorescence staining with rhodamine-conjugated rabbit anti-human immunoglobulin and with a mouse anti-CD5 monoclonal antibody revealed by a fluorescein-conjugated goat anti-mouse immunoglobulin. We found that CD5+ B cell levels (expressed as percentages of peripheral blood B lymphocytes) were significantly higher in group I (median 24; range 4-48) than in controls (median 14; range 0-36, P <0.001) and in group II (median 4; range 0-20, P <0.001). A follow-up study of 12 group I patients showed a significant decline in CD5+ B cell levels. The data obtained in our diabetic patients suggest that CD5+ B cells are expanded in the early phase of type 1 diabetes mellitus and may play a role in the autoimmune process of the disease.",
keywords = "Antibodies, Autoimmunity, B-lymphocytes, CD5 B cells, Type 1 (insulin-dependent) diabetes",
author = "R. Lorini and M. Massa and G. d'Annunzio and L. Cortona and {De Benedetti}, F. and A. Martini and F. Severi",
year = "1993",
doi = "10.1016/0168-8227(93)90140-Z",
language = "English",
volume = "19",
pages = "17--22",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - CD5-Positive B cells in type 1 (insulin-dependent) diabetic children

AU - Lorini, R.

AU - Massa, M.

AU - d'Annunzio, G.

AU - Cortona, L.

AU - De Benedetti, F.

AU - Martini, A.

AU - Severi, F.

PY - 1993

Y1 - 1993

N2 - We have measured CD5+ B cell levels in the peripheral blood of 35 type 1 (insulin-dependent) diabetic children, aged 1.1-21.2 years (10.7 ± 4.6 years). Patients were divided into two groups according to disease duration (group I <6 months and group II > 1.5 years). Group I included 18 patients and group II 17 patients. Thirty-nine healthy subjects, comparable for age and sex, served as controls. CD5+ B cells were identified by double immunofluorescence staining with rhodamine-conjugated rabbit anti-human immunoglobulin and with a mouse anti-CD5 monoclonal antibody revealed by a fluorescein-conjugated goat anti-mouse immunoglobulin. We found that CD5+ B cell levels (expressed as percentages of peripheral blood B lymphocytes) were significantly higher in group I (median 24; range 4-48) than in controls (median 14; range 0-36, P <0.001) and in group II (median 4; range 0-20, P <0.001). A follow-up study of 12 group I patients showed a significant decline in CD5+ B cell levels. The data obtained in our diabetic patients suggest that CD5+ B cells are expanded in the early phase of type 1 diabetes mellitus and may play a role in the autoimmune process of the disease.

AB - We have measured CD5+ B cell levels in the peripheral blood of 35 type 1 (insulin-dependent) diabetic children, aged 1.1-21.2 years (10.7 ± 4.6 years). Patients were divided into two groups according to disease duration (group I <6 months and group II > 1.5 years). Group I included 18 patients and group II 17 patients. Thirty-nine healthy subjects, comparable for age and sex, served as controls. CD5+ B cells were identified by double immunofluorescence staining with rhodamine-conjugated rabbit anti-human immunoglobulin and with a mouse anti-CD5 monoclonal antibody revealed by a fluorescein-conjugated goat anti-mouse immunoglobulin. We found that CD5+ B cell levels (expressed as percentages of peripheral blood B lymphocytes) were significantly higher in group I (median 24; range 4-48) than in controls (median 14; range 0-36, P <0.001) and in group II (median 4; range 0-20, P <0.001). A follow-up study of 12 group I patients showed a significant decline in CD5+ B cell levels. The data obtained in our diabetic patients suggest that CD5+ B cells are expanded in the early phase of type 1 diabetes mellitus and may play a role in the autoimmune process of the disease.

KW - Antibodies

KW - Autoimmunity

KW - B-lymphocytes

KW - CD5 B cells

KW - Type 1 (insulin-dependent) diabetes

UR - http://www.scopus.com/inward/record.url?scp=0027406569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027406569&partnerID=8YFLogxK

U2 - 10.1016/0168-8227(93)90140-Z

DO - 10.1016/0168-8227(93)90140-Z

M3 - Article

C2 - 7682495

AN - SCOPUS:0027406569

VL - 19

SP - 17

EP - 22

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 1

ER -